Swiss National Bank Applied Therapeutics Inc. Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.76 - $2.64 $28,348 - $98,472	-37,300 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$14.05 - $25.04 $37,935 - $67,608	2,700 Added 7.8%	37,300 $775,000
Q1 2021 May 07, 2021	BUY	$16.57 - $28.65 $69,594 - $120,330	4,200 Added 13.82%	34,600 $649,000
Q4 2020 Feb 05, 2021	BUY	$15.44 - $24.23 $15,440 - $24,230	1,000 Added 3.4%	30,400 $669,000
Q2 2020 Aug 05, 2020	BUY	$29.41 - $51.23 $864,654 - $1.51 Million	29,400 New	29,400 $1.06 Million

139

114M

1.62M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $446M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.